Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Change in Receivables: 2020-2025

Historic Change in Receivables for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Sep 2025 value amounting to -$5.1 million.

  • Maravai Lifesciences Holdings' Change in Receivables rose 14.99% to -$5.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.3 million, marking a year-over-year increase of 74.44%. This contributed to the annual value of -$14.4 million for FY2024, which is 82.99% up from last year.
  • Per Maravai Lifesciences Holdings' latest filing, its Change in Receivables stood at -$5.1 million for Q3 2025, which was down 921.16% from -$501,000 recorded in Q2 2025.
  • Maravai Lifesciences Holdings' Change in Receivables' 5-year high stood at $70.8 million during Q1 2021, with a 5-year trough of -$82.4 million in Q1 2023.
  • In the last 3 years, Maravai Lifesciences Holdings' Change in Receivables had a median value of -$5.1 million in 2025 and averaged -$10.4 million.
  • Examining YoY changes over the last 5 years, Maravai Lifesciences Holdings' Change in Receivables showed a top increase of 602.08% in 2021 and a maximum decrease of 9,882.85% in 2021.
  • Maravai Lifesciences Holdings' Change in Receivables (Quarterly) stood at $51.5 million in 2021, then tumbled by 49.99% to $25.8 million in 2022, then slumped by 65.92% to $8.8 million in 2023, then soared by 30.11% to $11.4 million in 2024, then increased by 14.99% to -$5.1 million in 2025.
  • Its last three reported values are -$5.1 million in Q3 2025, -$501,000 for Q2 2025, and -$10.2 million during Q1 2025.